follitropin alfa
Trade name: Gonal-F
Recombinant proteinapproved
Approved
Sep 29, 1997
Gonadotropin preparations are drugs that mimic the physiological effects of gonadotropins, used therapeutically mainly as fertility medication for ovarian hyperstimulation and ovulation induction. For example, the so-called menotropins consist of LH and FSH extracted from human urine from menopausal women. There are also recombinant variants. — Wikipedia
Clinical trial activity
202 trials · 187 clinical orgs · 3 marketing orgs
Phase 1
23
Phase 2
75
Phase 3
56
Phase 4
75
Earliest trial started Dec 1, 1999 (NCT01735422)
Timeline
1990s
- Sep 29, 1997
Earliest FDA Approval
- Sep 29, 1997
Merck Serono — NDA Secondary Org
- Sep 29, 1997
Organon — NDA Secondary Org
- Jan 1, 1999
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
- Absorption · Phase 1
- Aneuploidy · Phase 4
- Anovulation · Phase 4
- Anti-Mullerian Hormone · Phase 2/Phase 3
- Area Under Curve · Phase 1
- Clomiphene · Phase 4
- Drug Evaluation · Phase 2/Phase 3
- Embryo Loss · Phase 4
- Embryo Transfer · Phase 3
- Fertility · Phase 4
- Fertility Agents, Female · Phase 4
- Fertility Preservation · Phase 4
- Fertilization in Vitro · Phase 4
- Gonadotropin-Releasing Hormone · Phase 4
- Growth and Development · Phase 4
- Healthy Volunteers · Phase 4
- Hormones · Phase 3
- Hyperandrogenism · Phase 4
- Hypogonadism · Phase 4
- Infertility · Phase 4
- Infertility, Female · Phase 4
- Infertility, Male · Phase 4
- Kallmann Syndrome · Phase 4
- Obesity · Phase 1
- Oocyte Donation · Phase 3
- Ovarian Diseases · Phase 3
- Ovulation · Phase 4
- Ovulation Induction · Phase 4
- Ovum · Phase 4
- Pharmacokinetics · Phase 1
- Pituitary Diseases · Phase 3
- Polycystic Ovary Syndrome · Phase 4
- Pregnancy · Phase 3
- Pregnancy Complications · Phase 4
- Pregnancy Rate · Phase 2/Phase 3
- Progesterone · Early Phase 1
- Prostheses and Implants · Phase 4
- Quality of Life · Phase 4
- Reproduction · Phase 4
- Reproductive Health · Phase 4
- Reproductive Techniques, Assisted · Phase 4
- Safety · Phase 1
- Sperm Injections, Intracytoplasmic · Phase 4
- Sterilization · Phase 4
- Therapeutic Equivalency · Phase 1
- Transgender Persons · Phase 4
- Transsexualism · Phase 4
- Uterine Diseases · Phase 4
- Varicocele · Phase 4
- Vasodilation · Phase 4
Mechanism of action
FSHR agonist
GNRHR agonist
Approval history
- approvedSep 29, 1997
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Availability
- Discontinued
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaGonadotropin preparations ↗
- NCATS076WHW89TW ↗
- ChEMBLCHEMBL4297955 ↗
- ChEMBLCHEMBL1201692 ↗
- WikipediaGonal ↗
Also known as
- afolia
- bemfola
- da-3801
- fe 999049
- follicle stimulating hormone
- follicle stimulating hormone
- follicle stimulating hormone
- follicle-stimulating hormone
- follicle-stimulating hormone
- follitrophin alfa
- follitrophin alpha
- follitropin
- follitropin
- follitropin
- follitropin alfa
- follitropin alfa
- follitropin alfa
- follitropin alfa
- follitropin alfa
- follitropin alfa
- follitropin alfa
- follitropin-alfa
- follitropin alfa/beta
- follitropin alfa/beta
- follitropin alfa/beta
- follitropin alfa/beta
- follitropin alfa /lutropin alfa
- follitropin alpha
- follitropin alpha
- follitropin gamma
- follotropin
- follotropin recombinant
- fsh
- fsh
- fsh
- fsh
- fsh
- fsh-a
- fsh alpha
- gonal
- gonal
- gonal f
- gonal-f
- gonal-f
- gonal-f
- gonal-f
- gonalpalium
- hmg
- hmg
- human follicle stimulating hormone
- human follicle stimulating hormone
- human follicle stimulating hormone
- human fsh
- humegon
- normegon
- org 32489
- org-32489
- ovaleap
- ovaleap
- pergonal
- pergonal low lh
- pergoveris
- recfsh
- recombinant follicle stimulating hormone
- recombinant fsh
- recombinant human follicle-stimulating hormone (r-hfsh)
- rfsh-alpha
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07269327 | Phase 1 | Nov 24, 2025 | Merck KGaA |
| NCT07121751 | Phase 4 | Sep 1, 2025 | Dunamenti REK Istenhegyi IVF Center, Szeged University |
| NCT07097259 | Phase 1 | Jul 21, 2025 | Merck KGaA, Merck Serono |
| NCT06864793 | Phase 1 | May 31, 2025 | Qilu Pharmaceutical Co., Ltd. |
| NCT06921395 | Phase 4 | Feb 15, 2025 | LG |
| NCT06571214 | Phase 4 | Sep 1, 2024 | Nanjing University |
| NCT06414096 | Phase 1 | Jun 30, 2024 | University of Colorado, University of Colorado, Denver |
| NCT06481696 | N/A | Jun 1, 2024 | Andros Day Surgery Clinic |
| NCT06173869 | Phase 3 | Apr 1, 2024 | Ferring |
| NCT07128394 | N/A | Feb 1, 2024 | Nanjing University |
| NCT06175832 | Phase 4 | Jan 1, 2024 | Ghent University |
| NCT06134479 | Phase 3 | Dec 12, 2023 | Fundación Santiago Dexeus Font, Organon |
| NCT06091436 | Phase 3 | Mar 24, 2023 | GeneScience Pharmaceuticals Co., Ltd., Sun Yat-Sen University |
| NCT05670795 | N/A | Jan 1, 2023 | Bezmialem University |
| NCT05521828 | N/A | Dec 1, 2022 | Free University of Brussels |
| NCT05815719 | Phase 4 | Nov 17, 2022 | Instituto Bernabeu |
| NCT05405686 | Phase 4 | Sep 1, 2022 | Free University of Brussels, Merck KGaA |
| NCT05403476 | Phase 2 | Aug 16, 2022 | Ferring |
| NCT05266924 | Phase 3 | Jul 23, 2022 | Bharat Serums and Vaccines Limited |
| NCT05263388 | Phase 3 | Jul 14, 2022 | Ferring |
Showing 20 of 202 trials
Page 1 / 11
Organizations
Research & Development (187)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck KGaA | For profit | 28 | 26 | 4 | 1999 |
| Merck Serono | For profit | 24 | 3 | 5 | 1999 |
| Ferring | For profit | 20 | 17 | 3 | 2005 |
| Merck | For profit | 11 | 4 | 3 | 2004 |
| University of Valencia | Academic/Hospital | 8 | 6 | 3 | 2005 |
| Cairo University | Academic/Hospital | 6 | 6 | 4 | 2013 |
| Free University of Brussels | Academic/Hospital | 5 | 4 | 3 | 2013 |
| IBSA Institut Biochimique SA | For profit | 5 | 5 | 2 | 2001 |
| University of Copenhagen | Academic/Hospital | 5 | 4 | 1 | 2003 |
| Damascus University | Academic/Hospital | 4 | 4 | 1 | 2019 |
| Fundación Santiago Dexeus Font | Academic/Hospital | 4 | 4 | 2 | 2021 |
| Mansoura University | Academic/Hospital | 4 | 4 | 2 | 2008 |
| University of California, San Diego | Academic/Hospital | 4 | 4 | 2 | 2009 |
| Assiut University | Academic/Hospital | 3 | 3 | 2 | 2015 |
| Glycotope GmbH | For profit | 3 | 3 | 2 | 2011 |
| IVI Madrid | Academic/Hospital | 3 | 3 | 1 | 2009 |
| National Institutes of Health (NIH) | Government | 3 | 2 | 3 | 2000 |
| Peking University | Academic/Hospital | 3 | 2 | 1 | 2008 |
| Shahid Sadoughi University of Medical Science | Academic/Hospital | 3 | 3 | 2 | 2008 |
| University Hospital Quirón Dexeus, Barcelona | Academic/Hospital | 3 | 0 | 1 | 2021 |
187 organizations
Page 1 / 10
Marketing (3)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Merck Serono | For profit | NDA2 | Sep 29, 1997 |
| Organon | For profit | NDA2 | Sep 29, 1997 |
| Serono | For profit | NDA | — |